MALIGNANT RHABDOID TUMOR
Clinical trials for MALIGNANT RHABDOID TUMOR explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT RHABDOID TUMOR trials appear
Sign up with your email to follow new studies for MALIGNANT RHABDOID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells target tough childhood cancers
Disease control OngoingThis early-phase study is testing a new type of cell therapy called AGAR T cells in children and young adults with solid tumors that have come back or haven't responded to standard treatments. Doctors take a patient's own immune cells, modify them in a lab to better recognize and…
Matched conditions: MALIGNANT RHABDOID TUMOR
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for kids with Ultra-Rare, aggressive cancers
Disease control OngoingThis study is testing whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) can help control rare, aggressive cancers in children and young adults. The trial is for patients whose cancers have returned or haven't responded to standard treatments. Researchers…
Matched conditions: MALIGNANT RHABDOID TUMOR
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New hope for kids with devastating rare cancers
Disease control OngoingThis study is testing a drug called alisertib for children and young adults with rare, aggressive tumors called AT/RT and MRT. It is for patients whose cancer has come back and for those newly diagnosed. The goal is to see if adding alisertib to standard treatments helps control …
Matched conditions: MALIGNANT RHABDOID TUMOR
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Scientists test supercharged immune cells to attack tough cancers
Disease control OngoingThis early-stage study is testing a new type of treatment called CATCH T cells in adults with advanced solid tumors that have a specific marker (GPC3). Doctors take a patient's own immune cells, genetically modify them in a lab to better recognize and attack cancer, and then infu…
Matched conditions: MALIGNANT RHABDOID TUMOR
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC